Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 25.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 19.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 10.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 07.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 29.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers |
| 27.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers |
| 07.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain officers |
| 26.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certai |
| 21.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certai |
| 13.10.2023 | Item 4.02 — Bilanzkorrekturen | EXTREM | SEC | Exchange Act. ¨ Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed |
| 12.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ) of the Exchange Act. ¨ Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Cert |
| 09.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certai |
| 02.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certai |
| 16.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | e Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certai |
| 03.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ¨ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
| 02.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ¨ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
Stammdaten
Unternehmen & Branche
| Name | Aspira Women's Health Inc. |
|---|---|
| Ticker | AWHL |
| CIK | 0000926617 |
| Boerse | US |
| SIC | 2835 · In Vitro & In Vivo Diagnostic Substances |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 343,000 | -12,780,000 | -0.37 | 5,456,000 | -6,932,000 |
| 2025-09-30 | 10-Q | 89,000 | -4,892,000 | -0.13 | 7,296,000 | -4,344,000 |
| 2025-06-30 | 10-Q | 169,000 | -2,666,000 | -0.07 | 4,934,000 | -2,685,000 |
| 2025-03-31 | 10-Q | 2,279,000 | -1,853,000 | -0.09 | 6,716,000 | -60,000 |
| 2024-12-31 | 10-K | 4,000 | -13,094,000 | -0.93 | 5,491,000 | -2,563,000 |
| 2024-09-30 | 10-Q | 2,257,000 | -3,547,000 | -0.23 | 4,759,000 | -2,520,000 |
| 2024-06-30 | 10-Q | 2,423,000 | -3,530,000 | -0.28 | 5,491,000 | -3,709,000 |
| 2024-03-31 | 10-Q | 2,153,000 | -4,629,000 | -0.39 | 7,164,000 | -1,363,000 |
| 2023-12-31 | 10-K | 87,000,000 | -16,690,000 | -1.81 | 6,262,000 | -2,365,000 |
| 2023-09-30 | 10-Q | 2,217,000 | -4,706,000 | -0.48 | 8,662,000 | -659,000 |
| 2023-06-30 | 10-Q | 2,491,000 | -2,317,000 | -0.28 | 7,720,000 | -528,000 |
| 2023-03-31 | 10-Q | 2,316,000 | -6,578,000 | -0.79 | 11,496,000 | 827,000 |
| 2022-12-31 | 10-K | 8,184,000 | -29,885,000 | -3.85 | 17,373,000 | 6,979,000 |
| 2022-09-30 | 10-Q | 2,072,000 | -7,783,000 | -1.00 | 23,942,000 | 11,178,000 |
| 2022-06-30 | 10-Q | 2,066,000 | -8,243,000 | -1.10 | 24,016,000 | 14,122,000 |
| 2022-03-31 | 10-Q | 1,893,000 | -9,268,000 | -1.24 | 30,861,000 | 21,744,000 |
| 2021-12-31 | 10-K | 6,812,000 | -31,662,000 | -0.28 | 41,079,000 | 30,172,000 |
| 2021-09-30 | 10-Q | 1,666,000 | -9,707,000 | -0.09 | 48,047,000 | 38,504,000 |
| 2021-06-30 | 10-Q | 1,799,000 | -7,074,000 | -0.06 | 55,829,000 | 46,838,000 |
| 2021-03-31 | 10-Q | 1,496,000 | -5,920,000 | 62,297,000 | 52,325,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-09-17 | SCHULER JACK W | 10% Owner | Open Market Purchase | 1,111,111 | 0.45 | 499,999.95 | +281,8% | |
| 2025-09-17 | Fraser John D | Director | Open Market Purchase | 16,389 | 0.45 | 7,375.05 | +4,2% | |
| 2025-09-17 | cohen Jeffrey k | Director | Open Market Purchase | 55,556 | 0.45 | 25,000.20 | +14,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.